DIE WIRKUNG VON SOMATOSTATIN AUF STOFFWECHSELVERANDERUNGEN NACH ERCP

Translated title of the contribution: Effect of somatostatin on metabolic changes following ERCP

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

An investigation was carried out on the ameliorating effect of cyclic somatostatin on the biochemical changes and impairment of glucose tolerance which follow endoscopic retrograde pancreatography. Serum amylase and plasma insulin and glucagon levels were significantly lower in a group of 20 patients receiving somatostatin prior to pancreatic radiography than in 35 control patients without such pretreatment. (Maximum increases in control and somatosatin-pretreated patients, respectively were: amylase: 4695 ± 290; 1037 ± 155 U/l p <0.001; insulin; 504 ± 89; 179 ± 43 pmol/l p <0.001; glucagon: 394 ± 44; 62 ± 13 pmol/l p <0.05.) Impairment of glucose tolerance was also considerably less in the patients given prophylactic somatostatin. These results indicate that postpancreatographic metabolic abnormalities can be ameliorated, or possibly even prevented altogether, by prior administration of somatostatin.

Original languageGerman
Pages (from-to)261-265
Number of pages5
JournalWiener Klinische Wochenschrift
Volume94
Issue number10
Publication statusPublished - 1982

Fingerprint

Endoscopic Retrograde Cholangiopancreatography
Somatostatin
Amylases
Glucagon
Insulin
Glucose
Radiography
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

DIE WIRKUNG VON SOMATOSTATIN AUF STOFFWECHSELVERANDERUNGEN NACH ERCP. / Tulassay, Z.; Papp, J.; Koranyi, L.; Szathmári, M.; Tamás, G.

In: Wiener Klinische Wochenschrift, Vol. 94, No. 10, 1982, p. 261-265.

Research output: Contribution to journalArticle

@article{884a4b3ef7994d33a849bb6d92c71f5b,
title = "DIE WIRKUNG VON SOMATOSTATIN AUF STOFFWECHSELVERANDERUNGEN NACH ERCP",
abstract = "An investigation was carried out on the ameliorating effect of cyclic somatostatin on the biochemical changes and impairment of glucose tolerance which follow endoscopic retrograde pancreatography. Serum amylase and plasma insulin and glucagon levels were significantly lower in a group of 20 patients receiving somatostatin prior to pancreatic radiography than in 35 control patients without such pretreatment. (Maximum increases in control and somatosatin-pretreated patients, respectively were: amylase: 4695 ± 290; 1037 ± 155 U/l p <0.001; insulin; 504 ± 89; 179 ± 43 pmol/l p <0.001; glucagon: 394 ± 44; 62 ± 13 pmol/l p <0.05.) Impairment of glucose tolerance was also considerably less in the patients given prophylactic somatostatin. These results indicate that postpancreatographic metabolic abnormalities can be ameliorated, or possibly even prevented altogether, by prior administration of somatostatin.",
author = "Z. Tulassay and J. Papp and L. Koranyi and M. Szathm{\'a}ri and G. Tam{\'a}s",
year = "1982",
language = "German",
volume = "94",
pages = "261--265",
journal = "Wiener Klinische Wochenschrift",
issn = "0043-5325",
publisher = "Springer Wien",
number = "10",

}

TY - JOUR

T1 - DIE WIRKUNG VON SOMATOSTATIN AUF STOFFWECHSELVERANDERUNGEN NACH ERCP

AU - Tulassay, Z.

AU - Papp, J.

AU - Koranyi, L.

AU - Szathmári, M.

AU - Tamás, G.

PY - 1982

Y1 - 1982

N2 - An investigation was carried out on the ameliorating effect of cyclic somatostatin on the biochemical changes and impairment of glucose tolerance which follow endoscopic retrograde pancreatography. Serum amylase and plasma insulin and glucagon levels were significantly lower in a group of 20 patients receiving somatostatin prior to pancreatic radiography than in 35 control patients without such pretreatment. (Maximum increases in control and somatosatin-pretreated patients, respectively were: amylase: 4695 ± 290; 1037 ± 155 U/l p <0.001; insulin; 504 ± 89; 179 ± 43 pmol/l p <0.001; glucagon: 394 ± 44; 62 ± 13 pmol/l p <0.05.) Impairment of glucose tolerance was also considerably less in the patients given prophylactic somatostatin. These results indicate that postpancreatographic metabolic abnormalities can be ameliorated, or possibly even prevented altogether, by prior administration of somatostatin.

AB - An investigation was carried out on the ameliorating effect of cyclic somatostatin on the biochemical changes and impairment of glucose tolerance which follow endoscopic retrograde pancreatography. Serum amylase and plasma insulin and glucagon levels were significantly lower in a group of 20 patients receiving somatostatin prior to pancreatic radiography than in 35 control patients without such pretreatment. (Maximum increases in control and somatosatin-pretreated patients, respectively were: amylase: 4695 ± 290; 1037 ± 155 U/l p <0.001; insulin; 504 ± 89; 179 ± 43 pmol/l p <0.001; glucagon: 394 ± 44; 62 ± 13 pmol/l p <0.05.) Impairment of glucose tolerance was also considerably less in the patients given prophylactic somatostatin. These results indicate that postpancreatographic metabolic abnormalities can be ameliorated, or possibly even prevented altogether, by prior administration of somatostatin.

UR - http://www.scopus.com/inward/record.url?scp=0020030838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020030838&partnerID=8YFLogxK

M3 - Article

C2 - 6181617

AN - SCOPUS:0020030838

VL - 94

SP - 261

EP - 265

JO - Wiener Klinische Wochenschrift

JF - Wiener Klinische Wochenschrift

SN - 0043-5325

IS - 10

ER -